PEOPLE - Global Life Science Ventures makes appointment:
This article was originally published in Clinica
Executive Summary
Swiss- and German-based life sciences venture capital fund Global Life Science Ventures (Zug and Munich) has appointed partner Stephen McCormack as a managing director. Dr McCormack's successes include identifying IMI (retinal implants, Zurich) and Coapt (bioabsorbable implants, Palo Alto) for GLSV's investment portfolio.